Physician

Abdul Rahman Al Hout, MD

According to 2025 Medicare claims, Abdul Hout, MD (NPI: 1801381389) practices family practice in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is PROSPECT CHARTERCARE PHYSICIANS, LLC (NPI: 1629493135; TIN: 464690219) and primary practice location at 02917-2603. Hout is affiliated with the Prospect ACO Rhode Island (ACO ID: A4983), participating under the MSSP model.

Hout's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 112 traditional Medicare patients, billed 601 HCPCS/CPT codes, and received $41,375 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 5,962 prescription claims across 416 beneficiaries totaling $416,895 in drug costs, led by Jardiance (Empagliflozin). Open Payments data shows 138 records totaling $2,689. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $3,129 to $416,895. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$21K$43K2021 Medicare payment: $12,940 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $42,679 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $34,317 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $41,375 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202190174$12,940
2022190535$42,679
2023117434$34,317
2024112601$41,375

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$208K$417K2018 Drug cost: $3,129 (USD; Tot_Drug_Cst)2019 Drug cost: $56,604 (USD; Tot_Drug_Cst)2020 Drug cost: $116,283 (USD; Tot_Drug_Cst)2021 Drug cost: $178,710 (USD; Tot_Drug_Cst)2022 Drug cost: $283,970 (USD; Tot_Drug_Cst)2023 Drug cost: $379,615 (USD; Tot_Drug_Cst)2024 Drug cost: $416,895 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20182257$3,129
2019102786$56,604
20201581,708$116,283
20213862,351$178,710
20225334,513$283,970
20234555,516$379,615
20244165,962$416,895

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G0439Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit7878$130
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more89216$89
99443Telephone medical discussion with physician, 21-30 minutes2025$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more2123$48
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's71151$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
JardianceEmpagliflozin864,868$93,101
Trelegy ElliptaFluticasone/Umeclidin/Vilanter362,100$43,259
EliquisApixaban452,070$36,948
OzempicSemaglutide191,112$34,726
XareltoRivaroxaban201,740$31,481

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.138$2,689PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Abdul Rahman Al Hout, MD?

Tedicare shows public-source Medicare data for Abdul Rahman Al Hout, MD (NPI 1801381389), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abdul Rahman Al Hout, MD have ACO affiliation data?

Abdul Rahman Al Hout, MD is shown with ACO affiliation data for Prospect ACO Rhode Island (MSSP, ACO ID A4983).

What billing organization is linked to Abdul Rahman Al Hout, MD?

Abdul Rahman Al Hout, MD is linked to PROSPECT CHARTERCARE PHYSICIANS, LLC (billing NPI 1629493135) in the available physician profile data.

Does Abdul Rahman Al Hout, MD have Open Payments data?

Abdul Rahman Al Hout, MD has 138 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.